RGFP966 Suppresses Tumor Growth and Migration Through Inhibition of EGFR Expression in Hepatocellular Carcinoma Cells in vitro

PURPOSE: Histone deacetylase 3 (HDAC3) has been suggested to play a role in hepatocellular carcinoma (HCC). In the present report, we aimed to identify the effects of RGFP966, a specific HDAC3 inhibitor, on the cell proliferation and migration of HCC cell lines. METHODS: Human HCC cell lines, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xinying, Yang, Fan, Jiang, Hong, Fan, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959505/
https://www.ncbi.nlm.nih.gov/pubmed/32021097
http://dx.doi.org/10.2147/DDDT.S234871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959505/
https://www.ncbi.nlm.nih.gov/pubmed/32021097
http://dx.doi.org/10.2147/DDDT.S234871

Ejemplares similares